Jubilant Biosys

Jubilant Biosys Ltd, established in 1998, is a key entity within the Jubilant Pharmova group, specializing in comprehensive drug discovery and contract research services. With R&D centers strategically located in India and business offices extending across Asia and North America, the company leverages its global footprint to partner with leading worldwide healthcare firms. Jubilant Biosys offers end-to-end solutions, covering target discovery through to candidate selection, utilizing flexible business models such as Fee-for-Service (FFS), Full-Time Equivalent (FTE), and risk-shared partnerships. The company's operational scale is significant, employing between 1,000 and 5,000 professionals across its six global locations, underscoring its capacity for complex research projects and its commitment to client success.

The organization's expertise spans critical areas of pharmaceutical research, including discovery chemistry, structural biology, and integrated drug discovery. Jubilant Biosys is dedicated to fostering a collaborative environment, supported by state-of-the-art infrastructure and a talented scientific team. This focus enables the delivery of innovative solutions and accelerates the development pipeline for its partners. For insights into the people driving these advancements, you can Meet Jubilant Biosys's team. Their technical proficiency and scientific rigor are central to their value proposition in the competitive life sciences sector.

Operating within the Business Services industry, Jubilant Biosys provides essential services that support pharmaceutical and biotechnology companies in their quest for novel therapeutics. Their product portfolio includes contract research, drug discovery services, and development services, all aimed at enhancing efficiency and reducing time-to-market for new drugs. The company's revenue reached $528.4M, reflecting its substantial market presence and the demandView more...